| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,058 | 0,072 | 08.01. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| OBSERVE MEDICAL Aktie jetzt für 0€ handeln | |||||
| Mi | Observe Medical ASA: Financial calendar | - | Oslo Børs | ||
| 19.12.25 | Observe Medical ASA - Received Innovation Norway Loan Commitment of NOK 15 million | 2 | Cision News | ||
| 12.12.25 | OBSERVE MEDICAL ASA: Observe Medical is expanding the portfolio within the Urological drainage segment and continued market penetration | 1 | Cision News | ||
| 22.10.25 | Observe Medical ASA: Mandatory notification of trade by primary insider | 1 | Cision News | ||
| 22.10.25 | Observe Medical ASA: Mandatory notification of trade by close associates to primary insider | 2 | Cision News | ||
| 16.10.25 | Observe Medical ASA: Registration of new share capital | 1 | Oslo Børs | ||
| 14.10.25 | Observe Medical ASA: Mandatory notification of trade by close associates to primary insider | 2 | Cision News | ||
| 13.10.25 | Observe Medical ASA: Disclosure of major shareholdings following completion of the Private Placement and Subsequent Offering | 2 | Cision News | ||
| 13.10.25 | Observe Medical ASA: Final result of the subsequent offering and allocation of offer shares | 1 | Oslo Børs | ||
| 10.10.25 | OBSERVE MEDICAL ASA: Preliminary results of the subsequent offering | 1 | Cision News | ||
| 10.10.25 | Observe Medical ASA: Extraordinary general meeting held on 10 October 2025 | 1 | Oslo Børs | ||
| 10.10.25 | OBSERVE MEDICAL ASA: Last day of the subscription period in the subsequent offering | 2 | Oslo Børs | ||
| 07.10.25 | Observe Medical ASA: Observe Medical - Company presentation with trading update | - | Oslo Børs | ||
| 06.10.25 | Observe Medical ASA: Mandatory notification of trade by primary insider | 1 | Cision News | ||
| 25.09.25 | OBSERVE MEDICAL ASA: Observe Medical with progress in Italy: Major tender win, exclusive distribution agreement and significant order | 2 | Cision News | ||
| 25.09.25 | OBSERVE MEDICAL ASA: Approval and publication of prospectus, listing of the private placement shares and launch of subsequent offering | 1 | Oslo Børs | ||
| 24.09.25 | OBSERVE MEDICAL ASA: Resolution to increase the share capital in connection with subsequent offering | 2 | Cision News | ||
| 19.09.25 | Observe Medical ASA: Invitation to presentation with trading update 7 October, 2025 | 1 | Cision News | ||
| 19.09.25 | Observe Medical ASA: Notice of extraordinary general meeting on 10 October 2025 in connection with private placement | 1 | Cision News | ||
| 18.09.25 | Observe Medical ASA: Update on the subscription period in the subsequent offering | 1 | Cision News |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 46,530 | +0,48 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,010 | -0,43 % | EILMELDUNG: Fresenius Medical Care-Aktie bricht ein - Panik greift um sich! | ||
| FRESENIUS | 49,750 | +1,59 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| LUMEXA IMAGING | 17,730 | +2,37 % | Lumexa Imaging Draws Bullish Analyst Calls On Heels Of IPO | ||
| ALIGNMENT HEALTHCARE | 20,950 | 0,00 % | Where Alignment Healthcare Stands With Analysts | ||
| BRIGHTSPRING HEALTH SERVICES | 39,080 | 0,00 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| BETA BIONICS | 31,990 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics | ||
| PROCEPT BIOROBOTICS | 34,480 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| HEARTFLOW | 33,470 | 0,00 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 41,680 | -2,25 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| PROGYNY | 27,440 | 0,00 % | Progyny-Aktie: Truist Securities stuft auf 'Kaufen' hoch und verweist auf verbesserte Aussichten | ||
| ECKERT & ZIEGLER | 15,410 | -2,41 % | Eckert & Ziegler - Kurzbericht zur Aktienentwicklung | ||
| MIMEDX | 6,310 | -2,02 % | MiMedx Group, Inc: MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit-Wound Gel | MARIETTA, Ga., Dec. 22, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) ("MIMEDX" or the "Company") today announced it has entered into an exclusive agreement with Regen Lab USA LLC to... ► Artikel lesen | |
| NEUROPACE | 16,960 | +0,89 % | BDMD: Baird Medical Appoints Mark Saxton as U.S. CEO; Taps Veteran from NeuroPace, Smith + Nephew, and Covidien to Lead Commercial Expansion | NEW YORK, Dec. 3, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive... ► Artikel lesen | |
| BILLIONTOONE | 87,59 | 0,00 % | BillionToOne, Inc.: BillionToOne Reports Third Quarter 2025 Results | MENLO PARK, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen |